Myeloma Today: Spring 2022

The Spring Myeloma Today Edition has articles on the FDA’s approval of CARVYKTI™ CAR T-cell therapy, 2022 Brian D. Novis Research Grants, Bispecific Antibodies in Myeloma and more!

Download a Copy   |    Subscribe to Myeloma Today

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.